TULIP PORT

More and more cancer patients get chemoport implants rather than get injections repeatedly on peripheral blood vessels, as cancer drugs sometimes damage the small vessels and the surrounding tissue. A chemoport is the most reliable and convenient method of central venous access. MEDITULIP developed TULIP PORT, a chemoport to maximize patient comfort and safety by making the housing thin and small and the septum wide yet pressure-resistant. TULIP PORT is power-injectable and supports X-ray, CT and MRI examinations. Moreover, MEDITULIP uses more expensive, implantable-grade polysulfone material. MEDITULIP received regulatory approval in South Korea and is preparing for regulatory approval of its chemoports in other countries.